Polymorphisms in transporter genes and chemotherapy response in acute myeloid leukemia (AML) patients from Israel

被引：0
|
作者：
Risch, A
Müller, P
Asher, N
Bar-Cohen, S
Bartsch, H
Rund, D
机构：
[1] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
561
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [21] Management of Acute Myeloid Leukemia (AML) in Older Patients
    Maya Abdallah
    Zhuoer Xie
    Audrey Ready
    Dharmini Manogna
    Jason H. Mendler
    Kah Poh Loh
    Current Oncology Reports, 2020, 22
  • [22] Management of Acute Myeloid Leukemia (AML) in Older Patients
    Abdallah, Maya
    Xie, Zhuoer
    Ready, Audrey
    Manogna, Dharmini
    Mendler, Jason H.
    Loh, Kah Poh
    CURRENT ONCOLOGY REPORTS, 2020, 22 (10)
  • [23] Acute myeloid leukemia (AML): A study of 516 patients
    Kumar, L
    Menon, H
    Sharma, A
    Wadhwa, J
    Kumar, R
    Kochupillai, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 610S - 610S
  • [24] Receipt of Initial Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia (AML)
    Bhatt, Vijaya
    Shostrom, Valerie
    Gundabolu, Krishna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S280 - S281
  • [25] Quality of life and coping in adult patients with acute myeloid leukemia (AML) receiving intensive chemotherapy
    Schumacher, A
    Wewers, D
    Büchner, T
    Berdel, WE
    PSYCHO-ONCOLOGY, 2000, 9 (05) : S58 - S58
  • [26] The prognostic role of serum albumin in patients receiving induction chemotherapy for acute myeloid leukemia (AML)
    Sadrzadeh, Hossein
    Brunner, Andrew Mark
    Drapkin, Benjamin Jacob
    Babirak, Loren
    Werner, Lillian
    Ballen, Karen K.
    Amrein, Philip C.
    Attar, Eyal C.
    Chen, Yi-Bin Albert
    Spitzer, Thomas R.
    McAfee, Steven L.
    Neuberg, Donna S.
    Fathi, Amir Tahmasb
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Adenosine Monophosphate Activated Protein Kinase (AMPK) enhances chemotherapy response in Acute Myeloid Leukemia (AML)
    Ghiraldeli, Lais
    Anderson, Rebecca
    Pladna, Kristin
    Pardee, Timothy S.
    CANCER LETTERS, 2022, 535
  • [28] INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Lee, J. -H.
    Joo, Y. -D.
    Kim, H.
    Bae, S. H.
    Kim, M. K.
    Zang, D. Y.
    Lee, J. -L.
    Lee, G. W.
    Lee, J. -H.
    Park, J. -H.
    Kim, D. -Y.
    Lee, W. -S.
    Ryoo, H. M.
    Hyun, M. S.
    Kim, H. J.
    Min, Y. J.
    Lee, K. -H.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [29] The susceptibility of tumor cells to FAS-mediated apoptosis is predictive of response to induction chemotherapy in patients with acute myeloid leukemia (AML).
    Skacel, M
    Kalaycio, ME
    Hsi, ED
    BLOOD, 2000, 96 (11) : 319A - 319A
  • [30] High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)
    Butrym, Aleksandra
    Baczynska, Dagmara
    Tukiendorf, Andrzej
    Rybka, Justyna
    Dobosz, Tadeusz
    Jurczak, Wojciech
    Kuliczkowski, Kazimierz
    Mazur, Grzegorz
    BLOOD, 2014, 124 (21)
12345